Drawing for ZENRELIA

USPTO serial 79444723

ZENRELIA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
JANSON, ANDREW KYLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with ZENRELIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kathryn E. Smith

Kathryn E. Smith Wood Herron & Evans LLP600 Vine StreetSuite 2800Cincinnati, OH 45202

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations in the nature of insecticides for domesticated animals and companion animals; veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment, diagnosis, prevention and control of infectious diseases in food producing animals and livestock; veterinary preparations for enhancing reproduction in livestock; immunorestorative biopharmaceuticals for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; animal feed additives for use as nutritional supplements; veterinary preparations and animal feed additives for use in decreasing gas emissions from animals, animal carcasses, or animal waste; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; veterinary hormone preparations and hormone preparations in the nature of biological implants for animals, namely, progesterone, estrogen and testosterone; veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat; veterinary preparations for companion animals, namely, to treat and prevent parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders; veterinary preparations for companion animals for nonsurgical sterilization, namely, hormones for the control and prevention of reproductive functions; veterinary preparations for treating and preventing fleas, ticks, lice, flies, and mosquitos on companion animals; veterinary preparations, namely, vaccines for companion animals including horses.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 8, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 8, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 14, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 13, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 13, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 12, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Aug 12, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 23, 2026RFNTREFUSAL PROCESSED BY IB—
Jul 4, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 4, 2026RFRRREFUSAL PROCESSED BY MPU—
Jun 15, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 15, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 15, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 14, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 13, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2026DOCKASSIGNED TO EXAMINER—
Feb 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 26, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance